Our Company
CRO
CDMO
Stage wise
Custom Solutions
Investors
Our Responsibility
Careers
Resource Hub
Virtual Tour
CONTACT US
‹
Our Responsibility
Digital & AI (DnA)
EHS & Sustainability
Strategic Supply Chain Management
Quality
IP Protection & Data Security
Employee Welfare
Corporate Social Responsibility
Corporate Governance
Careers
Working at Aragen
Career Opportunities
Meet Our People
Caution Notice
Resource Hub
Virtual Tour
CONTACT US
Our Company
About Us
Our Journey
Leadership
Scientific and BD Team
Aragen Advantage
Global Locations
Media & Events
Recognitions
CRO
Small Molecules
Large Molecules/Biologics
Integrated Drug Discovery
Therapeutic areas
Chemistry
Medicinal Chemistry
Synthetic Chemistry
Analytical Chemistry
Specialty Chemistry
Biology
Cell and Protein Sciences
DMPK
Assay Development and Screening
In vivo Pharmacology
BioSafety
Cell Line Development
Antibody Discovery
Molecular Biology
Protein Expression & Purification
Biology
Cell and Protein Sciences
DMPK
Safety Pharmacology
In vivo Pharmacology
BioSafety
Fibrosis
Oncology
Immunology
Infectious Disease
Respiratory Disease
Pain & Inflammation
CardioVascular and Metabolic Diseases
Other Models
Enabling Solutions
Histology and Digital Pathology Services
In Vitro Pharmacology
CDMO
Small Molecules
Large Molecules
Drug Substance
Process Development & Optimization
Process Safety and Risk Management
Technology Transfer
Pilot Lab
IND Enabling Services
Process Validation & Qualification Services
Particle Science and Engineering Services
Process Optimization & Scale Up
Process Engineering
Regulatory Support
Drug Product
Preformulation
Toxicology Formulation
Clinical Formulation
Analytical Development
Method Development & Validation
Stability Studies
Extractable & Leachable Studies
Performance Chemicals
Process Research & Development
Custom Manufacturing
Custom Chemical Synthesis
Drug Substance
Performance Chemicals
Commercial Manufacturing
Process Development & Characterization
Analytical Services
GMP Manufacturing
Stage wise
Early Discovery
CMC
Clinical
Commercialization
Custom Solutions
Advance Modalities
HPAPI
PeptARx
Bioconjugation
CHOMax
TPD
Lipids
Molecular Glue
Oligos
RNA-Based
Investors
Annual Reports and Annual Returns
Corporate Governance
Close Search
Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
GET IN TOUCH
Brochure
Resin Recycling Studies
Download PDF
Project Outline
Analytical Method Transfer Protocol(s)
Analytical Methods Establishment
Scale Down model Protocol
Scale Down Model Establishment
SDM report
Resin Cycling protocol(s)
Study execution Sample analysis Data collection
Study report
Documentation
Activities are carried out with formal protocols
The protocols are discussed with, reviewed by and signed o by the client prior to initiation of experimental work
Protocols will include procedures as well as acceptance criteria
Reports are finalized after client review and sign-o by client
Client has the flexibility to arrange data and report in their format
Data
100% data verification is done by the QA personnel
All the raw data shall be available for client review and the same will be shared with client after study completion
Materials
Pre-approval of complete list of materials by client before initiating procurement
All residual materials and the used resin can be shipped back to client
Project Timeline
Description
Timeline
Analytical method transfer
12 weeks
Baseline runs
3 weeks
Chromatography resin
Number of runs
Timeline
Protein A chromatography (PAC)
240 Runs
18 to 20 weeks
Ion exchange chromatography (IEX)
120 Runs
11- 12 weeks
Learn more about our end-to-end capabilities
+
+